AlphaTON Capital Corp Files 6-K Report
Ticker: ATON · Form: 6-K · Filed: Sep 4, 2025 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Alphaton Capital CORP (ATON) |
| Form Type | 6-K |
| Filed Date | Sep 4, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $2,841,450 |
| Sentiment | neutral |
Sentiment: neutral
Topics: foreign-private-issuer, reporting, company-name-change
TL;DR
AlphaTON Capital Corp (fka Portage Biotech) filed a 6-K on 9/4/25. Standard foreign issuer report.
AI Summary
AlphaTON Capital Corp, formerly Portage Biotech Inc., filed a Form 6-K on September 4, 2025. The company, incorporated in the British Virgin Islands, is in the Pharmaceutical Preparations industry. This filing is a report of a foreign private issuer for the month of September 2025.
Why It Matters
This filing indicates ongoing reporting requirements for AlphaTON Capital Corp as a foreign private issuer, providing transparency to investors about its activities.
Risk Assessment
Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain specific financial or operational news that would inherently increase risk.
Key Numbers
- 001-40086 — SEC File Number (Identifies the company's filing with the SEC)
Key Players & Entities
- AlphaTON Capital Corp (company) — Registrant
- Portage Biotech Inc. (company) — Former company name
- 001-40086 (dollar_amount) — SEC File Number
- September 2025 (date) — Reporting period
- 20250904 (date) — Filing date
FAQ
What is the primary purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
When was AlphaTON Capital Corp previously known by another name?
AlphaTON Capital Corp was formerly known as Portage Biotech Inc., with a name change date of August 22, 2013.
What is AlphaTON Capital Corp's industry classification?
AlphaTON Capital Corp is classified under 'PHARMACEUTICAL PREPARATIONS' with the SIC code 2834.
Where is AlphaTON Capital Corp's principal executive office located?
The principal executive office is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
Does AlphaTON Capital Corp file annual reports under Form 20-F or 40-F?
AlphaTON Capital Corp indicates it files annual reports under cover of Form 20-F.
Filing Stats: 878 words · 4 min read · ~3 pages · Grade level 14.3 · Accepted 2025-09-04 17:00:04
Key Financial Figures
- $2,841,450 — ng an aggregate offering price of up to $2,841,450. The offer and sale of the Shares, if
Filing Documents
- f6k_081325.htm (6-K) — 14KB
- exh_11.htm (EX-1.1) — 219KB
- exh_51.htm (EX-5.1) — 34KB
- logo.jpg (GRAPHIC) — 20KB
- 0001171843-25-005747.txt ( ) — 296KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ALPHATON CAPITAL CORP (Registrant) Date: September 4, 2025 /s/ Andrea Park Andrea Park Chief Financial Officer